IL6 and neoplasm: Local inflammation typically manifests as immune responses within the tumor microenvironment, promoting tumor cell proliferation, migration, and drug resistance, while systemic inflammation exacerbates immune suppression throughout the body by releasing various inflammatory factors, such as TNF-α and IL-6, further promoting tumor metastasis and recurrence [18–20].